Personalized and Cell-based Antitumor Immunization MVX-ONCO-1 in Advanced HNSCC

Clinical trial NCT02999646 · COMPLETED

Trial details

NCT number: NCT02999646
Sponsor: Maxivax SA
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma

Start date: 2018-07-25
Primary completion: 2023-01-25
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.